317 related articles for article (PubMed ID: 31998606)
1. New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases.
Lu J; Shang X; Zhong W; Xu Y; Shi R; Wang X
Acta Pharm Sin B; 2020 Jan; 10(1):91-104. PubMed ID: 31998606
[TBL] [Abstract][Full Text] [Related]
2. Genic-intergenic polymorphisms of CYP1A genes and their clinical impact.
Kukal S; Thakran S; Kanojia N; Yadav S; Mishra MK; Guin D; Singh P; Kukreti R
Gene; 2023 Mar; 857():147171. PubMed ID: 36623673
[TBL] [Abstract][Full Text] [Related]
3. Interindividual variation in the metabolic activation of heterocyclic amines and their N-hydroxy derivatives in primary cultures of human mammary epithelial cells.
Stone EM; Williams JA; Grover PL; Gusterson BA; Phillips DH
Carcinogenesis; 1998 May; 19(5):873-9. PubMed ID: 9635877
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical approaches to studies of CYP1A localization and induction by xenobiotics in fish.
Goksøyr A; Husøy AM
EXS; 1998; 86():165-202. PubMed ID: 9949877
[TBL] [Abstract][Full Text] [Related]
5. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.
Snyderwine EG; Turesky RJ; Buonarati MH; Turteltaub KW; Adamson RH
Princess Takamatsu Symp; 1995; 23():69-77. PubMed ID: 8844797
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor activation and CYP1A induction by cooked food-derived carcinogenic heterocyclic amines in human HepG2 cell lines.
Sekimoto M; Sumi H; Hosaka T; Umemura T; Nishikawa A; Degawa M
Food Chem Toxicol; 2016 Nov; 97():256-264. PubMed ID: 27644595
[TBL] [Abstract][Full Text] [Related]
7. The inducibility of human cytochrome P450 1A by environmental-relevant xenobiotics in the human hepatoma derived cell line HepG2.
Rudzok S; Schmücking E; Graebsch C; Herbarth O; Bauer M
Environ Toxicol Pharmacol; 2009 Nov; 28(3):370-8. PubMed ID: 21784029
[TBL] [Abstract][Full Text] [Related]
8. Effect of CYP1A2 deficiency on heterocyclic amine DNA adduct levels in mice.
Snyderwine EG; Yu M; Schut HA; Knight-Jones L; Kimura S
Food Chem Toxicol; 2002 Oct; 40(10):1529-33. PubMed ID: 12387319
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines.
Hellmold H; Overvik E; Strömstedt M; Gustafsson JA
Carcinogenesis; 1993 Sep; 14(9):1751-7. PubMed ID: 8403195
[TBL] [Abstract][Full Text] [Related]
10. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
Sadrieh N; Snyderwine EG
Carcinogenesis; 1995 Jul; 16(7):1549-55. PubMed ID: 7614688
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of heterocyclic aromatic amines by human hepatocytes and cytochrome P4501A2.
Turesky RJ; Guengerich FP; Guillouzo A; Langouët S
Mutat Res; 2002 Sep; 506-507():187-95. PubMed ID: 12351158
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of cytochrome P-450 1A and P-glycoprotein expression by aryl hydrocarbon receptor agonists and thyroid hormone in Xenopus laevis liver and intestine.
Colombo A; Bonfanti P; Orsi F; Camatini M
Aquat Toxicol; 2003 Apr; 63(2):173-86. PubMed ID: 12657491
[TBL] [Abstract][Full Text] [Related]
13. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human.
Edwards RJ; Murray BP; Murray S; Schulz T; Neubert D; Gant TW; Thorgeirsson SS; Boobis AR; Davies DS
Carcinogenesis; 1994 May; 15(5):829-36. PubMed ID: 8200083
[TBL] [Abstract][Full Text] [Related]
14. Induction of cytochrome P450 1A5 mRNA, protein and enzymatic activities by dioxin-like compounds, and congener-specific metabolism and sequestration in the liver of wild jungle crow (Corvus macrorhynchos) from Tokyo, Japan.
Watanabe MX; Iwata H; Okamoto M; Kim EY; Yoneda K; Hashimoto T; Tanabe S
Toxicol Sci; 2005 Dec; 88(2):384-99. PubMed ID: 16177242
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity, DNA adduct formation and DNA repair induced by 2-hydroxyamino-3-methylimidazo[4,5-f]quinoline and 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in cultured human mammary epithelial cells.
Fan L; Schut HA; Snyderwine EG
Carcinogenesis; 1995 Apr; 16(4):775-9. PubMed ID: 7728954
[TBL] [Abstract][Full Text] [Related]
16. Ahr locus phenotype in congenic mice influences hepatic and pulmonary DNA adduct levels of 2-amino-3-methylimidazo[4,5-f]quinoline in the absence of cytochrome P450 induction.
Nerurkar PV; Schut HA; Anderson LM; Riggs CW; Fornwald LW; Davis CD; Snyderwine EG; Thorgeirsson SS; Weber WW; Rice JM; Levy GN
Mol Pharmacol; 1996 May; 49(5):874-81. PubMed ID: 8622637
[TBL] [Abstract][Full Text] [Related]
17. One dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) induces tumours in Min/+ mice by truncation mutations or LOH in the Apc gene.
Andreassen A; Møllersen L; Vikse R; Steffensen IL; Mikalsen A; Paulsen JE; Alexander J
Mutat Res; 2002 May; 517(1-2):157-66. PubMed ID: 12034317
[TBL] [Abstract][Full Text] [Related]
18. A Highly Selective Ratiometric Two-Photon Fluorescent Probe for Human Cytochrome P450 1A.
Dai ZR; Ge GB; Feng L; Ning J; Hu LH; Jin Q; Wang DD; Lv X; Dou TY; Cui JN; Yang L
J Am Chem Soc; 2015 Nov; 137(45):14488-95. PubMed ID: 26488456
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of DNA adduct formation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3-methylimidazo[4,5-f]quinoline by dietary indole-3-carbinol in female rats.
He YH; Schut HA
J Biochem Mol Toxicol; 1999; 13(5):239-47. PubMed ID: 10402557
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and beta-naphthoflavone-induced expression of a cytochrome P450 1A (CYP1A) gene from an anadromous river pufferfish, Takifugu obscurus.
Kim JH; Raisuddin S; Ki JS; Lee JS; Han KN
Mar Pollut Bull; 2008; 57(6-12):433-40. PubMed ID: 18304588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
